Type 2 diabetes mellitus (T2DM) is a systemic metabolic disorder that precipitates a spectrum of microvascular and macrovascular complications. Cardiovascular diseases stand as the leading cause of mortality among T2DM patients [1, 2]. Consequently, the accurate forecasting of major adverse cardiovascular...
The cardiorenal syndrome remains a challenge to appropriately diagnose, classify, and manage. Traditionally, worsening of kidney function in the setting of acutely decompensated heart failure (ADHF) was felt to be driven by reduced cardiac output. Since then, the recognition of several phenotypes of...
Duchenne muscular dystrophy (DMD) is a severe X-linked genetic disease that affects predominantly males (carrier females may also exhibit subtle myocardial changes), generating progressive muscle deterioration and severe motor impairments [1]. Considering their risk for developing cardiac pathologies...
Pulmonary hypertension (PH) is a common complication of MHD. Studies have shown that patients undergoing MHD with PH have significantly lower survival rates than those without PH. Prolonged elevation of pulmonary arterial pressure increases the afterload on the RV, ultimately leading to RV failure, which...
Lung cancer stands as one of the leading malignant tumors globally, characterized by a high incidence and mortality rate. Non-small-cell lung cancer (NSCLC) emerges as the major pathological category, accounting for 85% of lung cancer cases [1]. Due to the lack of early distinctive clinical signs, metastasis...